Publicaciones en colaboración con investigadores/as de Instituto de Biología Molecular y Celular del Cáncer de Salamanca / Centro de Investigación del Cáncer (146)

2024

  1. Non-apoptotic FAS signaling controls mTOR activation and extrafollicular maturation in human B cells

    Science Immunology, Vol. 9, Núm. 91

2023

  1. Immune stress suppresses innate immune signaling in preleukemic precursor B-cells to provoke leukemia in predisposed mice

    Nature Communications, Vol. 14, Núm. 1

  2. In-depth blood immune profiling of Good syndrome patients

    Frontiers in Immunology, Vol. 14

  3. KITD816V mutation in blood for the diagnostic screening of systemic mastocytosis and mast cell activation syndromes

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 5, pp. 1347-1359

  4. Predominantly Pro-Inflammatory Phenotype with Mixed M1/M2 Polarization of Peripheral Blood Classical Monocytes and Monocyte-Derived Macrophages among Patients with Excessive Ethanol Intake

    Antioxidants, Vol. 12, Núm. 9

2022

  1. The Euroflow PID Orientation Tube in the diagnostic workup of primary immunodeficiency: Daily practice performance in a tertiary university hospital

    Frontiers in Immunology, Vol. 13

  2. Transient Inhibition of the JAK/STAT Pathway Prevents B-ALL Development in Genetically Predisposed Mice

    Cancer research, Vol. 82, Núm. 6, pp. 1098-1109

2021

  1. Adverse prognostic impact of complex karyotype (≥3 cytogenetic alterations) in adult T-cell acute lymphoblastic leukemia (T-ALL)

    Leukemia Research, Vol. 109

  2. Automated identification of leukocyte subsets improves standardization of database-guided expert-supervised diagnostic orientation in acute leukemia: a EuroFlow study

    Modern Pathology, Vol. 34, Núm. 1, pp. 59-69

  3. Deciphering Intracellular Signaling Pathways in Tumoral Pathologies

    Methods in Molecular Biology (Humana Press Inc.), pp. 211-226

  4. Dynamic Intracellular Metabolic Cell Signaling Profiles During Ag-Dependent B-Cell Differentiation

    Frontiers in Immunology, Vol. 12

  5. Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in 1076 patients with acute myeloid leukemia

    Leukemia, Vol. 35, Núm. 8, pp. 2358-2370

  6. Neuro-immune interactions in the oncogenesis of multiple myeloma and their therapeutical relevance

    Transfuze a Hematologie Dnes, Vol. 27, Núm. 4, pp. 306-315

  7. Restoring the immunity in the tumor microenvironment: Insights into immunogenic cell death in onco-therapies

    Cancers, Vol. 13, Núm. 11

  8. Systematic and Rational Design of Protein Arrays in Noncontact Printers: Pipeline and Critical Aspects

    Methods in Molecular Biology (Humana Press Inc.), pp. 9-29

  9. Tracking the antibody immunome in sporadic colorectal cancer by using antigen self-assembled protein arrays

    Cancers, Vol. 13, Núm. 11

2020

  1. A Novel Cytotoxic Conjugate Derived from the Natural Product Podophyllotoxin as a Direct-Target Protein Dual Inhibitor

    Molecules, Vol. 25, Núm. 18

  2. Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma

    Blood Cancer Journal, Vol. 10, Núm. 10

  3. Detection of human p53 in-vitro expressed in a transcription-translation cell-free system by a novel conjugate based on cadmium sulphide nanoparticles

    Nanomaterials, Vol. 10, Núm. 5

  4. Immunogenomic identification and characterization of granulocytic myeloid-derived suppressor cells in multiple myeloma

    Blood, Vol. 136, Núm. 2, pp. 199-209